Press Release Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update Aug 14
Press Release Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder Aug 6